References
- Bielory L, Skoner DP, Blaiss MS, Leatherman B, Dykewicz MS, Smith N, Ortiz G, Hadley JA, Walstein N, Craig TJ, et al. Ocular and nasal allergy symptom burden in America: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys. Allergy Asthma Proc (2014); 35:211-8; PMID:24801463; http://dx.doi.org/10.2500/aap.2014.35.3750
- Nelson HS. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol (2005); 115:676-84; PMID:15805984; http://dx.doi.org/10.1016/j.jaci.2005.01.037
- Tsai JJ, Liao EC, Tsai FH, Hsieh CC, Lee MF. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus. J Asthma (2009); 46:165-70; PMID:19253124; http://dx.doi.org/10.1080/02770900802553110
- Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol (2014); 133:621-31; PMID:24581429; http://dx.doi.org/10.1016/j.jaci.2013.12.1088
- Georgitis JW, Reisman RE, Clayton WF, Mueller UR, Wypych JI, Arbesman CE. Local intranasal immunotherapy for grass-allergic rhinitis. J Allergy Clin Immunol (1983); 71:71-6; PMID:6337198; http://dx.doi.org/10.1016/0091-6749(83)90549-3
- Georgitis JW, Clayton WF, Wypych JI, Barde SH, Reisman RE. Further evaluation of local intranasal immunotherapy with aqueous and allergoid grass extracts. J Allergy Clin Immunol (1984); 74:694-700; PMID:6389648; http://dx.doi.org/10.1016/0091-6749(84)90232-X
- Liu YH, Kao MC, Lai YL, Tsai JJ. Efficacy of local nasal immunotherapy for Dp2-induced airway inflammation in mice: Using Dp2 peptide and fungal immunomodulatory peptide. J Allergy Clin Immunol (2003); 112:301-10; PMID:12897735; http://dx.doi.org/10.1067/mai.2003.1619
- Liu YH, Tsai JJ. Production of salivary immunoglobulin A and suppression of Dermatophagoides pteronyssinus-induced airway inflammation by local nasal immunotherapy. Int Arch Allergy Immunol (2005); 138:161-8; PMID:16192741; http://dx.doi.org/10.1159/000088438
- McEldowney SJ, Bush RK. Pollen immunotherapy: selection,prevention, and future directions. Curr Allergy Asthma Rep (2006); 6:420-6; PMID:16899205; http://dx.doi.org/10.1007/s11882-996-0016-5
- Di Gioacchino M, Cavallucci E, Ballone E, Cervone M, Di Rocco P, Piunti E, Filardo GS, Turi MC, Mangifesta R, Quecchia C, et al. Dose-dependent clinical and immunological efficacy of sublingual immunotherapy with mite monomeric allergoid. Int J Immunopathol Pharmacol (2012); 25:671-9; PMID:23058017
- Tsai JJ, Peng HJ, Han SH. Airway hyperreactivity modulated by immunotherapy with denatured ovalbumin in ovalbumin-sensitized guinea pigs. J Formos Med Assoc (1998); 97:626-32; PMID:9795531
- Norman PS, Ishizaka K, Lichtenstein LM, Adkinson NF Jr. Treatment of ragweed hay fever with urea-denatured antigen E. J Allergy Clin Immunol (1980); 66:336-41; PMID:6158532; http://dx.doi.org/10.1016/0091-6749(80)90030-5
- Chang YS, Kim YK, Kim SH, Park HW, Min KU, Kim YY, Cho SH. Murine subcutaneous immunotherapy models with beneficial immunological and physiological effects. Asia Pac Allergy (2013); 3:50-8; PMID:23403956; http://dx.doi.org/10.5415/apallergy.2013.3.1.50
- Taher YA, Henricks PA,van Oosterhout AJ. Allergen-specific subcutaneous immunotherapy in allergic asthma: Immunologic mechanisms and improvement. Libyan J Med (2010); 5; PMID:21483568; http://dx.doi.org/10.3402/ljm.v5i0.5303
- Marcucci F, Sensi LG, Caffarelli C, Cavagni G, Bernardini R, Tiri A, Riva G, Novembre E. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides. Allergy (2002); 57:23-8; PMID:11991284
- Maggi E, Vultaggio A, Matucci A. T-cell responses during allergen-specific immunotherapy. Curr Opin Allergy Clin Immunol (2012); 12:1-6; PMID:22157159; http://dx.doi.org/10.1097/ACI.0b013e32834ecc9a
- Liu L, Guo D, Liang Q, Ding S, Wu B, Zhang L, Li Q. The efficacy of sublingual immunotherapy with Dermatophagoides farinae vaccine in a murine atopic dermatitis model. Clin Exp Allergy (2014); PMID:25258013; http://dx.doi.org/10.1111/cea.12417
- Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol (2010); 125:S73-80; PMID:20176269; http://dx.doi.org/10.1016/j.jaci.2009.11.017
- Platzer B, Baker K, Vera MP, Singer K, Panduro M, Lexmond WS, Turner D, Vargas SO, Kinet JP, Maurer D, et al. Dendritic cell-bound IgE functions to restrain allergic inflammation at mucosal sites. Mucosal Immunol (2014); PMID:25227985
- Wegmann M, Hauber HP. Experimental approaches towards allergic asthma therapy-murine asthma models. Recent Pat Inflamm Allergy Drug Discov (2010); 4:37-53; PMID:19891606; http://dx.doi.org/10.2174/187221310789895612
- Blaser K. [Immunological principles of allergen-specific immune therapy]. HNO (2008); 56:759-63; PMID:18648758; http://dx.doi.org/10.1007/s00106-008-1731-0
- Higgins BG, Francis HC, Yates C, Warburton CJ, Fletcher AM, Pickering CA, Woodcock AA. Environmental exposure to air pollution and allergens and peak flow changes. Eur Respir J (2000); 16:61-6; PMID:10933086; http://dx.doi.org/10.1034/j.1399-3003.2000.16a11.x
- Tochigi R. [Clinical studies on bronchial hypersensitivity to methacholine in bronchial asthma of children]. Arerugi (1972); 21:28-39; PMID:5025148